Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19. Boucau J, Uddin R, Marino C, Regan J, et al. Clin Infect Dis 2022 Jun 23. pii: 6614635. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Boucau J, Uddin R, Marino C, Regan J, et al. Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19. Clin Infect Dis 2022 Jun 23. pii: 6614635. doi: 10.1093.
PMID: 35737946